Brief: Astrazeneca Pharma India Receives Permission To Import Osimertinib Tablets
29/05/2025 07:38
May 29 (Reuters) - Astrazeneca Pharma India Ltd ASTR.NS: RECEIVES PERMISSION TO IMPORT OSIMERTINIB TABLETS Source text: ID:nNSE5r4vcG Further company coverage: ASTR.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma India Receives Permission To Import And Sell Trastuzumab Deruxtecan For Additional Indication
Brief: Astrazeneca Pharma Says Bhavana Agrawal Resigns As CFO
Brief: Astrazeneca Pharma India Receives Permission To Import And Sell Benralizumab For Additional Indication
Brief: Astrazeneca Pharma India Receives Permission To Import Benralizumab (Fasenra) For Additional Indication
Brief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan